Description
Letrozole is a non-steroidal aromatase inhibitor widely researched for its capacity to inhibit estrogen synthesis by blocking the aromatase enzyme. It is extensively studied in hormone-related therapies, particularly in breast cancer and endocrine regulation research. Hilma Biocare’s Letrozole 2.5mg tablets come in a pack of 30, formulated to ensure high purity and consistent dosage suitable for precise laboratory and preclinical applications.
For research use only. Not intended for human or veterinary use.